HCW Biologics (HCWB) Misses Q2 EPS by 679c

HCW Biologics (NASDAQ: HCWB) reported Q2 EPS of ($6.79). Revenue for the quarter came in at $1.31 million.

For earnings history and earnings-related data on HCW Biologics (HCWB) click here.

You May Also Be Interested In

• Tesla readies August launch of CyberCab - The Information
• Four Tree Island Advisory calls DoubleDown $11.25 offer too low
• NASA awards Firefly Aerospace spacecraft processing contract at Vandenberg